fda warning letters bpc 157 2024 2025 BPC-157 Approval Status: Is It Approved for Human Use? FDA Warns Companies for Illegally
Description
The active content has been identified as the N-terminal acetylated 17-23 fragment of Thymosin Beta-4 (Ac-LKKTETQ)
It is great for strains, sprains, tendinitis and muscle issues
Most people experience significant improvement within six weeks to four months with proper care
Always read the label and consult your doctor for advice
